GE HealthCare reports fourth quarter and full year 2025 financial results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
GE HealthCare (GEHC) PT Raised to $91 at BTIG
February 4, 2026 12:33 PM ESTBTIG analyst Ryan Zimmerman raised the price target on GE HealthCare (NASDAQ: GEHC) to $91.00 (from $87.00) while maintaining a Buy rating.
The analyst comments "We maintain our Buy and raise our PT to $91 (from $87) following 4Q25 results. Order growth came in at ~2.0% with a Book-to-Bill ratio of 1.06x off a more challenging... More
GE HealthCare (GEHC) Tops Q4 EPS by 4c, Beats on Revenue; Offers Guidance
February 4, 2026 6:22 AM ESTGE HealthCare (NASDAQ: GEHC) reported Q4 EPS of $1.44, $0.04 better than the analyst estimate of $1.40. Revenue for the quarter came in at $5.7 million versus the consensus estimate of $5.6 million.
Today, the Company introduces 2026 full-year guidance metrics as follows:
Organic revenue growth* of 3.0% to 4.0% year-over-year... More
